Filing Details
- Accession Number:
- 0001632388-15-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-10 15:11:37
- Reporting Period:
- 2015-02-10
- Filing Date:
- 2015-02-10
- Accepted Time:
- 2015-02-10 15:11:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1618561 | Nexvet Biopharma Plc | NVET | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632741 | Ii Fund Healthcare Pacific Asia Atf Ltd Management Funds One | Level 11, 20 Hunter Street Sydney C3 2000 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2015-02-10 | 530,972 | $0.00 | 530,972 | No | 4 | C | Direct | |
Ordinary Shares | Acquisiton | 2015-02-10 | 242,400 | $0.00 | 773,372 | No | 4 | C | Direct | |
Ordinary Shares | Acquisiton | 2015-02-10 | 100,000 | $10.00 | 873,372 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Series A Investment Preference Shares | Disposition | 2015-02-10 | 530,972 | $0.00 | 530,972 | $0.00 |
Ordinary Shares | Series B Preference Shares | Disposition | 2015-02-10 | 242,400 | $0.00 | 242,400 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Reflects automatic conversion of Series A Investment Preference Shares into ordinary shares on a one-for-one basis upon the completion of the initial public offering of Issuer's ordinary shares.
- Justin Epstein, as the authorized director of One Funds Management Limited, the trustee for Asia Pacific Healthcare Fund II, has voting and dispositive power with respect to these reported securities, but disclaims beneficial ownership thereof except to the extent of his pecuniary interest therein.
- Reflects automatic conversion of Series B Preference Shares into ordinary shares on a one-for-one basis upon the completion of the initial public offering of Issuer's ordinary shares.